Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study

1995 ◽  
Vol 61 (4) ◽  
pp. 465-469 ◽  
Author(s):  
Hiroshi Saito ◽  
Yasushi Soma ◽  
Junichi Koeda ◽  
Toyohito Wada ◽  
Hitoshi Kawaguchi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Control Study ◽  
Occult Blood ◽  
Case Control ◽  
Fecal Occult Blood ◽  
Hemagglutination Test ◽  
Fecal Occult ◽  
Risk Of Mortality ◽  
Control Study ◽  
Blood Screening

scholarly journals An Evaluation of Mass Screening Using Fecal Occult Blood Test for Colorectal Cancer in Japan: A Case-Control Study

1993 ◽  
Vol 84 (11) ◽  
pp. 1110-1112 ◽  
Author(s):  
Nobuo Hiwatashi ◽  
Tomizo Morimoto ◽  
Akira Fukao ◽  
Hirofusa Sato ◽  
Nobuyuki Sugahara ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Blood Test ◽  
Fecal Occult Blood Test ◽  
Case Control Study ◽  
Occult Blood ◽  
Case Control ◽  
Fecal Occult Blood ◽  
Occult Blood Test ◽  
Fecal Occult ◽  
Control Study

Colorectal Cancer Screening: A Community Case-Control Study of Proctosigmoidoscopy, Barium Enema Radiography, and Fecal Occult Blood Test Efficacy

1999 ◽  
Vol 74 (12) ◽  
pp. 1207-1213 ◽  
Author(s):  
Sidna M. Scheitel ◽  
David A. Ahlquist ◽  
Peter C. Wollan ◽  
Philip T. Hagen ◽  
Marc D. Silverstein
Keyword(s):  
Colorectal Cancer ◽  
Blood Test ◽  
Fecal Occult Blood Test ◽  
Case Control Study ◽  
Occult Blood ◽  
Case Control ◽  
Fecal Occult Blood ◽  
Occult Blood Test ◽  
Fecal Occult ◽  
Control Study

scholarly journals Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study

1999 ◽  
Vol 79 (3-4) ◽  
pp. 680-683 ◽  
Author(s):  
J Faivre ◽  
M A Tazi ◽  
T El Mrini ◽  
C Lejeune ◽  
A M Benhamiche ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Mortality ◽  
Case Control Study ◽  
Occult Blood ◽  
Case Control ◽  
Faecal Occult Blood ◽  
Faecal Occult ◽  
Colorectal Cancer Mortality ◽  
Control Study ◽  
Blood Screening

Fecal occult blood screening for colorectal cancer in a Veterans Administration hospital

1983 ◽  
Vol 145 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Stephen J. Sontag ◽  
Carol Durczak ◽  
Gerard V. Aranha ◽  
Gregorio Chejfec ◽  
William Frederick ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Occult Blood ◽  
Veterans Administration ◽  
Fecal Occult Blood ◽  
Fecal Occult ◽  
Administration Hospital ◽  
Blood Screening ◽  
Veterans Administration Hospital

Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer

2004 ◽  
Vol 20 (4) ◽  
pp. 434-439 ◽  
Author(s):  
Catherine Lejeune ◽  
Patrick Arveux ◽  
Vincent Dancourt ◽  
Sophie Béjean ◽  
Claire Bonithon-Kopp ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cost Effectiveness ◽  
Screening Test ◽  
Occult Blood ◽  
Sensitivity Analyses ◽  
Fecal Occult Blood ◽  
Decision Analysis Model ◽  
Economic Data ◽  
Fecal Occult ◽  
Blood Screening

Objectives: Clinical trials have demonstrated that fecal occult blood screening for colorectal cancer can significantly reduce mortality. However, to be deemed a priority from a public health policy perspective, any new program must prove itself to be cost-effective. The objective of this study was to assess the cost-effectiveness of screening for colorectal cancer using a fecal occult blood screening test, the Hemoccult-II, in a cohort of 100,000 asymptomatic individuals 50–74 years of age.Methods: A decision analysis model using a Markov approach simulates the trajectory of the cohort allocated either to screening or no screening over a 20-year period through several health states. Clinical and economic data used in the model came from the Burgundy trial, French population-based studies, and Registry data.Results: Modeling biennial screening versus the absence of screening over a 20-year period resulted in a 17.7 percent mortality reduction and a discounted incremental cost-effectiveness ratio of 3,357 € per life-year gained among individuals 50–74 years of age. Sensitivity analyses performed on epidemiological and economic data showed the strong impact on the results of colonoscopy cost, of compliance to screening, and of specificity of the screening test.Conclusions: Cost-effectiveness estimates and sensitivity analyses suggest that biennial screening for colorectal cancer with fecal occult blood test could be recommended from the age of 50 until 74. Our findings support the attempts to introduce large-scale population screening programs.

Sign in / Sign up

Export Citation Format

Share Document